Hilton Blake T, Yusufov Miryam, Rosellini Anthony J, Taghian Nadine R, Weiss Roger D, Griffin Margaret L, McHugh R Kathryn
Division of Alcohol, Drugs, and Addiction, McLean Hospital, 115 Mill Street, Belmont, MA 02478, United States of America; Department of Psychiatry, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, United States of America.
Department of Psychiatry, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, United States of America; Department of Psychosocial Oncology and Palliative Care, Dana Farber Cancer Institute, 450 Brookline Avenue, JF 707, Boston, MA 02215, United States of America.
J Subst Abuse Treat. 2022 Jan;132:108507. doi: 10.1016/j.jsat.2021.108507. Epub 2021 Jun 3.
Anxiety sensitivity, or the fear of anxiety-related sensations, has demonstrated relevance to a broad range of psychiatric conditions, including substance use disorders (SUDs). Anxiety sensitivity is typically measured through self-report instruments, most commonly the Anxiety Sensitivity Index-3 (ASI-3). Despite the widespread use of the ASI-3 in studies of SUDs, little is known about its psychometric properties within this population. Patients on an inpatient detoxification unit seeking treatment for SUDs (N = 1248) completed a battery of self-report measures, including the ASI-3. Psychometric properties of the ASI-3 were examined. An exploratory factor analysis with half of the sample (n = 624) supported a 3-factor structure corresponding to the ASI-3 subscales (Social Concerns, Cognitive Concerns, Physical Concerns). Confirmatory factor analysis was used to validate this 3-dimensional structure in a separate subsample (n = 624), resulting in adequate fit when testing a second-order hierarchical model. Internal consistency and convergent and discriminant validity results also supported the use of the ASI-3 in people with SUDs. Despite its widespread use in SUD research, this is the first psychometric investigation of the ASI-3 among individuals seeking treatment for SUDs.
焦虑敏感性,即对与焦虑相关的感觉的恐惧,已被证明与广泛的精神疾病有关,包括物质使用障碍(SUDs)。焦虑敏感性通常通过自我报告工具来测量,最常用的是焦虑敏感性指数-3(ASI-3)。尽管ASI-3在SUDs研究中被广泛使用,但对于其在该人群中的心理测量特性却知之甚少。在住院戒毒单位寻求SUDs治疗的患者(N = 1248)完成了一系列自我报告测量,包括ASI-3。对ASI-3的心理测量特性进行了检查。对一半样本(n = 624)进行的探索性因素分析支持了与ASI-3分量表(社会关注、认知关注、身体关注)相对应的三因素结构。验证性因素分析用于在另一个子样本(n = 624)中验证这种三维结构,在测试二阶层次模型时拟合良好。内部一致性以及收敛效度和区分效度结果也支持在SUDs患者中使用ASI-3。尽管ASI-3在SUDs研究中被广泛使用,但这是首次对寻求SUDs治疗的个体进行的ASI-3心理测量研究。